data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Contribute
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
Personal Finance
Alts
Best Real Estate Crowdfunding Platforms
REITs Versus Crowdfunding
How to Invest in Artwork
Best Alternative Investments
Best Alternative Investment Platforms
Crypto
Cannabis
News
Earnings
Interviews
Deals
Regulations
Psychedelics
TV
YouTube
Video
Podcasts
Trading School
My Stocks
Tools
Premium
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Voyager Therapeutics
(NASDAQ:VYGR)
$6.08
0.17[2.88%]
At close: Jul 1
$6.08
00
After Hours: 4:00PM EDT
Day High/Low5.63 - 6.17
52 Week High/Low2.46 - 10.6
Open / Close5.89 / 6.08
Float / Outstanding27.1M / 38.5M
Vol / Avg.216.5K / 547K
Mkt Cap233.8M
P/E-
50d Avg. Price6.18
Div / Yield-
Payout Ratio-
EPS-0.56
Total Float27.1M

Voyager Therapeutics (NASDAQ:VYGR), Quotes and News Summary

Voyager Therapeutics (NASDAQ: VYGR)

Day High/Low5.63 - 6.17
52 Week High/Low2.46 - 10.6
Open / Close5.89 / 6.08
Float / Outstanding27.1M / 38.5M
Vol / Avg.216.5K / 547K
Mkt Cap233.8M
P/E-
50d Avg. Price6.18
Div / Yield-
Payout Ratio-
EPS-0.56
Total Float27.1M
Benzinga - Jun 24, 2022, 9:08AM
Benzinga - Jun 24, 2022, 5:25AM
Benzinga - May 19, 2022, 8:38AM
Benzinga - May 19, 2022, 6:03AM
Benzinga - May 5, 2022, 10:47AM
Benzinga - May 4, 2022, 4:31PM
Benzinga - Apr 21, 2022, 11:15AM
Benzinga - Apr 21, 2022, 11:10AM
Benzinga - Mar 22, 2022, 7:15AM
Benzinga - Mar 8, 2022, 3:30PM
Benzinga - Mar 8, 2022, 6:27AM
Benzinga - Mar 8, 2022, 6:17AM
Benzinga - Mar 8, 2022, 4:54AM
Benzinga - Dec 14, 2021, 9:24AM
Benzinga - Nov 19, 2021, 8:57AM
Benzinga - Nov 19, 2021, 7:33AM
Benzinga - Sponsored
load more
Sector: Health Care.Industry: Biotechnology
Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. The company operates in a single segment of developing and commercializing gene therapies.
Read More

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-08-05
REV
Q1 2022Est.ActualSurprise
EPS-0.560
REV658.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Voyager Therapeutics Questions & Answers

Q
How do I buy Voyager Therapeutics (VYGR) stock?
A

You can purchase shares of Voyager Therapeutics (NASDAQ: VYGR) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Voyager Therapeutics's (VYGR) competitors?
Q
What is the target price for Voyager Therapeutics (VYGR) stock?
A

The latest price target for Voyager Therapeutics (NASDAQ: VYGR) was reported by Chardan Capital on Wednesday, November 3, 2021. The analyst firm set a price target for 4.00 expecting VYGR to fall to within 12 months (a possible -34.21% downside). 2 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Voyager Therapeutics (VYGR)?
A

The stock price for Voyager Therapeutics (NASDAQ: VYGR) is $6.08 last updated July 1, 2022, 8:00 PM UTC.

Q
Does Voyager Therapeutics (VYGR) pay a dividend?
A

There are no upcoming dividends for Voyager Therapeutics.

Q
When is Voyager Therapeutics (NASDAQ:VYGR) reporting earnings?
A

Voyager Therapeutics’s Q2 earnings are confirmed for Friday, August 5, 2022.

Q
Is Voyager Therapeutics (VYGR) going to split?
A

There is no upcoming split for Voyager Therapeutics.

Q
What sector and industry does Voyager Therapeutics (VYGR) operate in?
A

Voyager Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.